- About US
- Drug Discovery
- News & Publications
- Contact Us
Around the world there are still many diseases for which no effective treatments exist and many patients who do not have adequate access to the medicines they need. As a global pharmaceutical company addressing these unmet medical needs, Eisai is committed to making contributions to better healthcare for patients and their families around the world through its business activities.
Eisai Co., Ltd. is a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide healthcare system. Eisai employs approximately 11,000 employees worldwide.
The Eisai Group has defined its R&D activities as product creation and established a new organization, Eisai Product Creation Systems (EPCS). Under the new EPCS, the Eisai Group aspires to become more patient oriented in product creation. The goal of EPCS is to better understand the emotions and realities of patients in order to provide innovative treatments that address their apparent and latent issues, thereby improving their quality of life. EPCS combines venture-like productivity and speed with the knowledge resources of a global pharmaceutical company. Under this system, the Eisai Group aims to shorten development time to ensure the early creation of novel, innovative drugs that satisfy unmet medical needs or that improve the quality of life of patients and their caregivers.